HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pennock, J. L. Articles by Shumway, N. E. Search for Related Content PubMed PubMed Citation Articles by Pennock, J. L. Articles by Shumway, N. E.

The Journal of Thoracic and Cardiovascular Surgery, Vol 83, 168-177, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost

JL Pennock, PE Oyer, BA Reitz, SW Jamieson, CP Bieber, J Wallwork, EB Stinson and NE Shumway

Two hundred twenty-seven cardiac transplant procedures have been performed in 206 patients from January, 1968, to April, 1981. Postoperative survival rates, calculated by the actuarial method for program years 1968 to 1973 (66 patients), are 44%, 33%, 27%, 21%, and 18% at 1, 2, 3, 4, and 5 years after transplantation, respectively. Postoperative survival rates for program years 1974 to 1981 (140 patients) are 63%, 55%, 51, 44%, and 39% at 1, 2, 3, 4, and 5 years after transplantation, respectively. This increase results primarily from improvement in survival achieved in the first 3 postoperative months (59% +/- 7%, 1968 to 1973, versus 80% +/- 40%, 1974 to 1980), reflecting improved patient management. Infection remains the primary cause of death following transplantation (76/131 patients, 58%), followed by acute rejection (24/181, 18.3%), graft arteriosclerosis (14/131, 10.7%), and malignancy (6/131, 4.6%). The development of graft arteriosclerosis has been examined in 85 one-year survivors studied by annual coronary arteriograms. Coronary lesions of varying severity have developed in 21 patients. HLA-A2 incompatibility was associated with a higher incidence of graft arteriosclerosis than was apparent for all other A locus incompatibilities (p less than 0.0003). Lymphoma has been shown to be associated with younger recipient age, a primary disease diagnosis of idiopathic cardiomyopathy, and retransplantation. One hundred six patients have survived at least 1 year after transplantation; 97% were in NYHA Class 1 at that time interval and 82% returned to employment or activity of choice. The longest survival time is new 11 years, 3 months. Cardiac transplantation can be considered "reasonable and therapeutic treatment to extend life" in selected individuals.

This article has been cited by other articles:

				C. Hur, N. S. Nishioka, and G. S. Gazelle Cost-Effectiveness of Aspirin Chemoprevention for Barrett's Esophagus J Natl Cancer Inst, February 18, 2004; 96(4): 316 - 325. [Abstract] [Full Text] [PDF]

				M. Sharifi, Y. Siraj, J. O'Donnell, and V. J. Pompili Coronary Angioplasty and Stenting in Orthotopic Heart Transplants: A Fruitful Act or a Futile Attempt? Angiology, October 1, 2000; 51(10): 809 - 815. [Abstract] [PDF]

				D. A. Rossignol, B. Kipreos, K. Akosah, and P. K. Mohanty Accelerated Transplant Coronary Artery Disease and Massive Silent Acute Myocardial Infarction in a Heart Transplant Patient: A Case Report and Brief Review of Literature Angiology, November 1, 1999; 50(11): 947 - 953. [Abstract] [PDF]

				B. L. Knisely, L. A. Mastey, J. Collins, J. E. Kuhlman, and A. N. Leung Imaging of Cardiac Transplantation Complications RadioGraphics, March 1, 1999; 19(2): 321 - 341. [Abstract] [Full Text] [PDF]

				T. O. Tengs, G. Meyer, J. E. Siegel, J. S. Pliskin, J. D. Graham, and M. C. Weinstein Oregon's Medicaid Ranking and Cost- Effectiveness: Is There Any Relationship? Med Decis Making, June 1, 1996; 16(2): 99 - 107. [Abstract] [PDF]

				Y. Morishita, T. Kawakami, K. Arikawa, M. Hashiguchi, T. Harada, Y. Moriyama, Y. Iguro, A. Taira, and H. Sakamoto Long-Distance Transportation of Canine Hearts for Transplantation: The First Experience in Japan Vascular and Endovascular Surgery, January 1, 1990; 24(1): 1 - 6. [Abstract] [PDF]

				M. Paquin Societal and Ethical Considerations of Artificial Hearts J Biomater Appl, January 1, 1986; 1(1): 157 - 167. [Abstract] [PDF]

				Report of the Massachusetts Task Force on Organ Transplantation J. Law Med. Ethics, February 1, 1985; 13(1): 8 - 26. [PDF]